PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG) BY MONOCLONAL-ANTIBODY (MAB) TO A COMPLEMENTARY PEPTIDE FOR THE MAIN IMMUNOGENIC REGION (MIR) OF THE ACETYLCHOLINE-RECEPTOR (ACHR)
S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG) BY MONOCLONAL-ANTIBODY (MAB) TO A COMPLEMENTARY PEPTIDE FOR THE MAIN IMMUNOGENIC REGION (MIR) OF THE ACETYLCHOLINE-RECEPTOR (ACHR), The FASEB journal, 9(4), 1995, pp. 784-784